AVE 0.00% 0.2¢ avecho biotechnology limited

incredible, page-27

  1. 2,888 Posts.
    lightbulb Created with Sketch. 603
    I suspect that the review of cash availability position actually started much earlier than indicated in the latest announcement and suggest that the appointment of 3 new non executive directors in August 2010 to enhance product commercialisation activities would have been a catalyst.The availability of cash is a key ingredient for any company progress.It is for this reason that I think this finance package has not been put together in haste and that a good outcome will eventuate.
    The newsletter could feature a regular commentary on the adequacy funding thus keeping shareholders aware of the company's financial condition.
    Kens
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.